PLEASANTON, CA--(Marketwire - May 07, 2008) - Lipid Sciences, Inc. (NASDAQ: LIPD) announced the issuance of two strategic patents from the U.S. Patent and Trademark Office. The first of these patents, “Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content,” covers the Company’s HDL Selective Delipidation technology. HDL Selective Delipidation modifies naturally occurring HDL resulting in the creation of a substantially more effective scavenger form of HDL. This “energized” HDL has been shown to dramatically increase reverse cholesterol transport, the body’s process for removing cholesterol from plaque in the cardiovascular system.
